Resultados da pesquisa - Maxim Norkin

Refinar resultados
  1. 1
    High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer

    High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer Por Maxim Norkin, Paloma Ordóñez‐Morán, Joerg Huelsken

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Id2 controls specification of Lgr5 <sup>+</sup> intestinal stem cell progenitors during gut development

    Id2 controls specification of Lgr5 <sup>+</sup> intestinal stem cell progenitors during gut development Por Lira Nigmatullina, Maxim Norkin, Margarita M. Dzama, Berith Messner, Sergi Sayols, Natalia Soshnikova

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy

    IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy Por Laurent Beziaud, C. Megan Young, Angela Madurga Alonso, Maxim Norkin, Anna Rita Minafra, Joerg Huelsken

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    In Vitro Evaluation of the Safety and Efficacy of Cibisatamab Using Adult Stem Cell-Derived Organoids and Colorectal Cancer Spheroids

    In Vitro Evaluation of the Safety and Efficacy of Cibisatamab Using Adult Stem Cell-Derived Organoids and Colorectal Cancer Spheroids Por Victor Anstett, Elisa Heinzelmann, Francesco Piraino, Aline Roch, Antonius Chrisnandy, Maxim Norkin, Virginie Garnier, Krisztián Homicskó, Sylke Hoehnel, Nathalie Brandenberg

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma

    Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma Por George M. Ramzy, Maxim Norkin, Thibaud Koessler, Lionel Voirol, Matthieu Tihy, Dina Hany, Thomas McKee, Frédéric Ris, Nicolas Buchs, Mylène Docquier, Christian Toso, Laura Rubbia‐Brandt, Gaetan Bakalli, Stéphane Guerrier, Joerg Huelsken, Patrycja Nowak‐Sliwinska

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide Por Shannon R. McCurdy, Mei-Jie Zhang, Andrew St. Martin, Monzr M. Al Malki, Asad Bashey, Sameh Gaballa, Daniel A. Keesler, Mehdi Hamadani, Maxim Norkin, Miguel‐Angel Perales, Ran Reshef, Vanderson Rocha, Rizwan Romee, Melhem Solh, Álvaro Urbano-Ispízua, Edmund K. Waller, Ephraim J. Fuchs, Mary Eapen

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

    Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis Por Pierre Teira, Minoo Battiwalla, Muthalagu Ramanathan, A. John Barrett, Kwang Woo Ahn, Min Chen, Jaime S. Green, Ayman Saad, Joseph H. Antin, Bipin N. Savani, Hillard M. Lazarus, Matthew D. Seftel, Wael Saber, David I. Marks, Mahmoud Aljurf, Maxim Norkin, John R. Wingard, Caroline A. Lindemans, Michael Boeckh, Marcie L. Riches, Jeffery J. Auletta

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  8. 8
    National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

    National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide Por Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani, Brian C. Shaffer, Nirav N. Shah, Alisha Mussetter, Xiao-Ying Tang, John M. McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M. Hardy, Hannah Choe, Richard F. Ambinder, Claudio Anasetti, Miguel‐Angel Perales, Stephen R. Spellman, Alan Howard, Krishna V. Komanduri, Leo Luznik, Maxim Norkin, Joseph A. Pidala, Voravit Ratanatharathorn, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Javier Bolaños‐Meade

    Publicado em 2021
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

    Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-... Por Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani, Brian C. Shaffer, Nirav N. Shah, Alisha Mussetter, Xiao-Ying Tang, John M. McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M. Hardy, Hannah Choe, Richard F. Ambinder, Claudio Anasetti, Miguel‐Angel Perales, Stephen R. Spellman, Alan Howard, Krishna V. Komanduri, Leo Luznik, Maxim Norkin, Joseph A. Pidala, Voravit Ratanatharathorn, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Javier Bolaños‐Meade

    Publicado em 2022
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

    Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes Por Christine Duncan, Navneet S. Majhail, Ruta Brazauskas, Zhiwei Wang, Jean‐Yves Cahn, Haydar Frangoul, Robert J. Hayashi, Jack W. Hsu, Rammurti T. Kamble, Kimberly A. Kasow, Nandita Khera, Hillard M. Lazarus, Alison W. Loren, David I. Marks, Richard T. Maziarz, Paulette Mehta, Kasiani C. Myers, Maxim Norkin, Joseph A. Pidala, David L. Porter, Vijay Reddy, Wael Saber, Bipin N. Savani, Harry C. Schouten, Amir Steinberg, Donna A. Wall, Anne B. Warwick, William A. Wood, Lolie C. Yu, David A. Jacobsohn, Mohamed L. Sorror

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study

    Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study Por Kasiani C. Myers, Elissa Furutani, Edie Weller, Bradford Siegele, Ashley Galvin, Valérie Arsenault, Blanche P. Alter, Farid Boulad, Carlos E. Bueso‐Ramos, Lauri M. Burroughs, Paul Castillo, James A. Connelly, Stella M. Davies, Courtney D. DiNardo, Iftikhar Hanif, Richard Ho, Nicole Karras, Michelle Manalang, Lisa J. McReynolds, Taizo A. Nakano, Grzegorz Nalepa, Maxim Norkin, Matthew J. Oberley, Etan Orgel, Yves D. Pastore, Joseph Rosenthal, Kelly Walkovich, Jordan H. Larson, Maggie Malsch, M. Tarek Elghetany, Mark D. Fleming, Akiko Shimamura

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

    Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and min... Por Veronika Bachanová, D I Marks, M-J Zhang, Hai‐Lin Wang, Marcos de Lima, Mahmoud Aljurf, Martha Arellano, Andrew Artz, Ulrike Bacher, J-Y Cahn, Y-B Chen, Edward A. Copelan, William R. Drobyski, Robert Peter Gale, John P. Greer, Vikas Gupta, Gregory A. Hale, Partow Kebriaei, Hillard M. Lazarus, Ian D. Lewis, Victor Lewis, Jane L. Liesveld, Mark R. Litzow, Alison W. Loren, Alan M. Miller, Maxim Norkin, Betül Oran, Joseph Pidala, Jacob M. Rowe, Bipin N. Savani, Wael Saber, Ravi Vij, Edmund K. Waller, Peter H. Wiernik, Daniel J. Weisdorf

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research

    Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Resear... Por Vikas Gupta, Adriana K. Malone, Parameswaran Hari, Kwang Woo Ahn, Zhen‐Huan Hu, Robert Peter Gale, Karen K. Ballen, Mehdi Hamadani, Eduardo Olavarría, Aaron T. Gerds, Edmund K. Waller, Luciano J. Costa, Joseph H. Antin, Rammurti T. Kamble, Koen M. Van Besien, Bipin N. Savani, Harry C. Schouten, Jeff Szer, Jean‐Yves Cahn, Marcos J. de Lima, Baldeep Wirk, Mahmoud Aljurf, Uday Popat, Nelli Bejanyan, Mark R. Litzow, Maxim Norkin, Ian D. Lewis, Gregory A. Hale, Ann E. Woolfrey, Alan M. Miller, Celalettin Üstün, Madan Jagasia, Michael Lill, Richard T. Maziarz, Jorge E. Cortés, Matt Kalaycio, Wael Saber

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Secondary solid cancer screening following hematopoietic cell transplantation

    Secondary solid cancer screening following hematopoietic cell transplantation Por Yoshihiro Inamoto, Nirali N. Shah, Bipin N. Savani, Bronwen E. Shaw, Allistair Abraham, Ibrahim Ahmed, Görgün Akpek, Yoshiko Atsuta, K. Scott Baker, Grzegorz Basak, Menachem Bitan, Zachariah DeFilipp, Tara Gregory, Hildegard Greinix, Mehdi Hamadani, Betty K. Hamilton, Robert J. Hayashi, David A. Jacobsohn, Rammurti T. Kamble, Kimberly A. Kasow, Nandita Khera, Hillard M. Lazarus, Adriana K. Malone, Maria Teresa Lupo Stanghellini, Steven Margossian, Lori Muffly, Maxim Norkin, Muthalagu Ramanathan, Nina Salooja, Hélène Schoemans, John R. Wingard, Baldeep Wirk, William A. Wood, Agnes S. M. Yong, C. Duncan, Mary E.D. Flowers, Navneet S. Majhail

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  15. 15
    Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

    Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT Por Zachariah DeFilipp, Rafael F. Duarte, John A. Snowden, Navneet S. Majhail, David Greenfield, José López‐Miranda, Mutlu Arat, K. Scott Baker, Linda J. Burns, C. Duncan, Maria Gilleece, Gregory A. Hale, Mehdi Hamadani, Betty K. Hamilton, William J. Hogan, J Hsu, Yoshihiro Inamoto, Rammurti T. Kamble, Maria Teresa Lupo Stanghellini, Adriana K. Malone, Philip L. McCarthy, Mohamad Mohty, Maxim Norkin, Pamela Paplham, Muthalagu Ramanathan, John M. Richart, Nina Salooja, Harry C. Schouten, Hélène Schoemans, Adriana Seber, Amir Steinberg, Baldeep Wirk, William A. Wood, Minoo Battiwalla, Mary E.D. Flowers, Bipin N. Savani, Bronwen E. Shaw

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  16. 16
    Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT

    Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT Por Zachariah DeFilipp, Rafael F. Duarte, John A. Snowden, Navneet S. Majhail, David Greenfield, José López‐Miranda, Mutlu Arat, K. Scott Baker, Linda J. Burns, Christine Duncan, Maria Gilleece, Gregory A. Hale, Mehdi Hamadani, Betty K. Hamilton, William J. Hogan, Jack W. Hsu, Yoshihiro Inamoto, Rammurti T. Kamble, Maria Teresa Lupo Stanghellini, Adriana K. Malone, Philip L. McCarthy, Mohamad Mohty, Maxim Norkin, Pamela Paplham, Muthalagu Ramanathan, John M. Richart, Nina Salooja, Harry C. Schouten, Hélène Schoemans, Adriana Seber, Amir Steinberg, Baldeep Wirk, William A. Wood, Minoo Battiwalla, Mary E.D. Flowers, Bipin N. Savani, Bronwen E. Shaw

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation

    Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation Por Karen K. Ballen, Kwang Woo Ahn, Min Chen, Hisham Abdel‐Azim, Ibrahim Ahmed, Mahmoud Aljurf, Joseph H. Antin, Ami S. Bhatt, Michael Boeckh, George Chen, Christopher E. Dandoy, Biju George, Mary J. Laughlin, Hillard M. Lazarus, Margaret L. MacMillan, David A. Margolis, David I. Marks, Maxim Norkin, Joseph Rosenthal, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Jan Storek, Paul Szabolcs, Celalettin Üstün, Michael R. Verneris, Edmund K. Waller, Daniel J. Weisdorf, Kirsten M. Williams, John R. Wingard, Baldeep Wirk, Tom F.W. Wolfs, Jo‐Anne H. Young, Jeffery J. Auletta, Krishna V. Komanduri, Caroline A. Lindemans, Marcie L. Riches

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia

    The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia Por Moshe Yeshurun, Daniel Weisdorf, Jacob M. Rowe, Martin S. Tallman, Mei-Jie Zhang, Hai-Lin Wang, Wael Saber, Marcos de Lima, Brenda M. Sandmaier, Geoffrey L. Uy, Rammurti T. Kamble, Mitchell S. Cairo, Brenda Cooper, Jean‐Yves Cahn, Siddhartha Ganguly, Bruce M. Camitta, Leo F. Verdonck, Christopher E. Dandoy, Miguel Ángel Díaz, Bipin N. Savani, Biju George, Jane L. Liesveld, Joseph P. McGuirk, Michael Byrne, Michael R. Grunwald, William R. Drobyski, Michael A. Pulsipher, Hisham Abdel‐Azim, Tim Prestidge, Matthew J. Wieduwilt, Rodrigo Martino, Maxim Norkin, Amer Beitinjaneh, Sachiko Seo, Taiga Nishihori, Baldeep Wirk, Haydar Frangoul, Asad Bashey, Shahram Mori, David I. Marks, Veronika Bachanová

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

    Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD Por Benjamin Watkins, Muna Qayed, Courtney McCracken, Brandi Bratrude, Kayla Betz, Yvonne Suessmuth, Alison Yu, Shauna Sinclair, Scott N. Furlan, Steven E. Bosinger, Victor Tkachev, James Rhodes, Audrey G. Tumlin, Alexandria Narayan, Kayla Cribbin, Scott Gillespie, Ted Gooley, Marcelo C. Pasquini, Kyle Hebert, Urvi Kapoor, André Rogatko, Mourad Tighiouart, Sungjin Kim, Catherine Bresee, Sung Won Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C. Harris, David A. Jacobsohn, Nahal Lalefar, Maxim Norkin, Nosha Farhadfar, Michael A. Pulsipher, Shalini Shenoy, Aleksandra Petrović, Kirk R. Schultz, Gregory A. Yanik, Edmund K. Waller, John E. Levine, James L.M. Ferrara, Bruce R. Blazar, Amelia Langston, John Horan, Leslie S. Kean

    Publicado em 2021
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

    Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome Por Alyssa L. Kennedy, Kasiani C. Myers, James R. Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani, Gwen M. Muscato, Robert H. Klein, Kaitlyn Ballotti, Shanshan Liu, Chad E. Harris, Ashley Galvin, Maggie Malsch, David C. Dale, John M. Gansner, Taizo A. Nakano, Alison A. Bertuch, Adrianna Vlachos, Jeffrey M. Lipton, Paul Castillo, James A. Connelly, Jane E. Churpek, John Edwards, Nobuko Hijiya, Richard Ho, Inga Hofmann, James N. Huang, Sioḃán Keel, Adam J. Lamble, Bonnie Lau, Maxim Norkin, Elliot Stieglitz, Wendy Stock, Kelly Walkovich, Steffen Boettcher, Christian Brendel, Mark D. Fleming, Stella M. Davies, Edie Weller, Christopher D. Bahl, Scott L. Carter, Akiko Shimamura, R. Coleman Lindsley

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: